Viewing Study NCT00382668


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2026-02-09 @ 8:05 PM
Study NCT ID: NCT00382668
Status: COMPLETED
Last Update Posted: 2011-04-14
First Post: 2006-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Liver Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hepatically impaired View